Market revenue in 2023 | USD 3,433.6 million |
Market revenue in 2030 | USD 6,956.0 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Hba1c tests |
Fastest growing segment | HGB/HCT tests |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Complete blood count, HGB/HCT tests, Basic metabolic panel, BUN creatinine tests, Electrolytes testing, HbA1c tests, Comprehensive metabolic panel tests, Liver panel tests, Renal panel tests, Lipid panel tests |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, Labcorp Holdings Inc, ARUP Laboratories, OPKO Health Inc, Clinical Reference Laboratory, Sonic Healthcare Ltd, Cinven, Unilabs |
Hba1c tests was the largest segment with a revenue share of 12.42% in 2023. Horizon Databook has segmented the France clinical laboratory tests market based on complete blood count, hgb/hct tests, basic metabolic panel, bun creatinine tests, electrolytes testing, hba1c tests, comprehensive metabolic panel tests, liver panel tests, renal panel tests, lipid panel tests covering the revenue growth of each sub-segment from 2018 to 2030.
The clinical laboratory tests market in France is expected to witness lucrative growth rate over the forecast period, due to the increase in prevalence of infectious diseases, rapid technological advancements, and rise in awareness about infectious diseases.
Initiatives undertaken by the France government to improve the healthcare services and infrastructure in the country are expected to drive the market. The growing geriatric population in the country is also at a higher risk of chronic diseases. As per the World Bank, in 2019, over 20% of the population in France was 65 and over (i.e., over 67 million individuals in France are categorized as the elderly).
However, a shift in consumer preference from laboratory-based tests and general tests to home-based point-of-care & rapid tests may restrain the growth of the market in the region. However, the high burden of chronic diseases, such as diabetes, dyslipidemia, and heart-related diseases, is expected to boost the demand for clinical laboratory tests over the forecast period.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account